Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

218 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-α for the treatment of chronic hepatitis C in HIV-infected patients: the PERICO trial.
Labarga P, Barreiro P, da Silva A, Guardiola JM, Rubio R, Aguirrebengoa K, Miralles P, Portu J, Téllez MJ, Morano L, Castro A, Pineda JA, Terrón A, Hernández-Quero J, Mariño A, Ríos MJ, Echeverría S, Asensi V, Vispo E, Soriano V; PERICO Study Group. Labarga P, et al. Among authors: asensi v. J Infect Dis. 2012 Sep 15;206(6):961-8. doi: 10.1093/infdis/jis449. Epub 2012 Jul 17. J Infect Dis. 2012. PMID: 22807523 Clinical Trial.
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
García-Samaniego J, Rodríguez M, Berenguer J, Rodríguez-Rosado R, Carbó J, Asensi V, Soriano V. García-Samaniego J, et al. Among authors: asensi v. Am J Gastroenterol. 2001 Jan;96(1):179-83. doi: 10.1111/j.1572-0241.2001.03374.x. Am J Gastroenterol. 2001. PMID: 11197250
Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.
Martín-Carbonero L, Benhamou Y, Puoti M, Berenguer J, Mallolas J, Quereda C, Arizcorreta A, Gonzalez A, Rockstroh J, Asensi V, Miralles P, Laguno M, Moreno L, Girón JA, Vogel M, García-Samaniego J, Nuñez M, Romero M, Moreno S, de la Cruz JJ, Soriano V. Martín-Carbonero L, et al. Among authors: asensi v. Clin Infect Dis. 2004 Jan 1;38(1):128-33. doi: 10.1086/380130. Epub 2003 Dec 8. Clin Infect Dis. 2004. PMID: 14679458
Treatment of chronic hepatitis C in HIV-infected patients with interferon alpha-2b plus ribavirin.
Pérez-Olmeda M, Soriano V, Asensi V, Morales D, Romero M, Ochoa A, Sánchez-Montero F, Santin M, Guardiola J, Blanch J, Núñez M, Jiménez-Nácher I, García-Samaniego J; HCV/HIV Spanish Study Group. Pérez-Olmeda M, et al. Among authors: asensi v. AIDS Res Hum Retroviruses. 2003 Dec;19(12):1083-9. doi: 10.1089/088922203771881176. AIDS Res Hum Retroviruses. 2003. PMID: 14709244 Free article. Clinical Trial.
Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations.
Soriano V, Miró JM, García-Samaniego J, Torre-Cisneros J, Núñez M, del Romero J, Martín-Carbonero L, Castilla J, Iribarren JA, Quereda C, Santín M, González J, Arribas JR, Santos I, Hernández-Quero J, Ortega E, Asensi V, del Pozo MA, Berenguer J, Tural C, Clotet B, Leal M, Mallolas J, Sánchez-Tapias JM, Moreno S, Gatell JM, Téllez MJ, Rubio R, Ledesma E, Domingo P, Barreiro P, Pedreira J, Romero M, González-Lahoz J, Lissen E. Soriano V, et al. Among authors: asensi v. J Viral Hepat. 2004 Jan;11(1):2-17. doi: 10.1046/j.1365-2893.2003.00491.x. J Viral Hepat. 2004. PMID: 14738553 Review.
Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy.
Asensi V, Martín-Roces E, Carton JA, Collazos J, Maradona JA, Alonso A, Medina M, Aburto JM, Martínez E, Rojo C, Bustillo E, Fernández C, Arribas JM. Asensi V, et al. Clin Infect Dis. 2004 Jul 15;39(2):240-7. doi: 10.1086/421774. Epub 2004 Jul 1. Clin Infect Dis. 2004. PMID: 15307034
Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.
Barrios A, Negredo E, Domingo P, Estrada V, Labarga P, Asensi V, Morales D, Santos J, Clotet B, Soriano V; EFADITE Study Group. Barrios A, et al. Among authors: asensi v. Antivir Ther. 2005;10(7):825-32. Antivir Ther. 2005. PMID: 16312178 Clinical Trial.
218 results